Biomedical Engineering Reference
In-Depth Information
S. No.
Delivery System
Composition
Route of Administration
Characteristics
References
1.
Cationic lipid-
based vectors:
liposomes/
lipoplexes
Lipids such as lipofectin, RNAifect, oligofectamine,
lipofectamine, cardiolipin, and transIT TKO are
commonly used transfection reagents composed of
cationic lipids and colipids like ceramide carbomoyl
spermine (CCS) and dioleoyl phosphatidylethanolamine
(DOPE), dioleoyl phosphatidylcholine (DOPC), N -(1-
(2,3-dioleoyloxy)propyl)- N , N , N -trimethylammonium
chloride (DOTAP), 3ss[ N -( N ,N dimethylaminoethane)
carbamoyl]-cholesterol (DC-CHOL), 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC), N -[1-(2,3-
dioleyloyx) propyl]- N - N - N -trimethyl ammonium
chloride (DOTMA), dioctadecyldimethylammonium
bromide (DODAB)cholesterol, etc.
Intravenous,
intracerebroventricular,
intravaginal
Have improved pharmacokinetic
properties with reduced systemic
toxicity, but may precipitate acute
immune responses
Protect oligonucleotides
from degradation and provide
controlled drug delivery
[12,155-161]
2.
Polymeric
micelles
Polymers like poly(aspartate hydrazone adriamycin),
poly(ethylene oxide)-block-poly(aspartic acid),
pluronics, poly( N -isopropylacrylamide), poly(ethylene
glycol)-block-poly(ethylenimine), N -(2-hydroxypropyl)
methacrylamide (HPMA) copolymers, etc.
Intravenous,
intraperitoneal
Protect oligonucleotides
from degradation and provide
controlled drug delivery
[160,162-165]
3.
Polymeric
nanoparticles
Polymers like gelatin, chitosan, albumin, sodium
alginate, poly(lactide- co -glycolide), polyanhydrides,
hyaluronic acid, cyclodextrin, gold nanoparticles, silica
nanoparticles, etc.
Intravenous
Have improved pharmacokinetic
properties with reduced systemic
toxicity but may cause acute
immune responses, protect
oligonucleotides from degradation,
and provide controlled drug
delivery
[12,155,160,166-170]
4.
Lipid-polymer
hybrid systems
Consists of hybrid systems like liposome-entrapped
polylysine-condensed DNA, lipid-coated precondensed
polylysine-DNA, poly(propylacrylic acid)-coated
cationic lipid-DNA conjugate, etc.
Intravenous
Provide better protection
against nucleases and more
efficient transfection than
uncoated lipoplexes or polyplexes
[160,171-174]
Search WWH ::




Custom Search